Kevin Byrne

Kevin Byrne, MD

Languages spoken: English
Schedule an Appointment

Clinical Locations

HMHI (UNI) Park City Behavioral Health Clinic

Park City
435-658-9998

  • Kevin Byrne, MD, Assistant Professor (Clinical), earned his medical degree at Boston University School of Medicine. He completed Adult Psychiatry residency at the University of Utah Spencer Fox Eccles School of Medicine where he served as Chief Resident. He is board certified in Psychiatry by the ABPN. Dr. Byrne's clinical interests include psychiatric care for people with cancer, existential distress, psychedelic treatments for mental health, treatment-resistant mood disorders, trauma and its related conditions, and advanced psychopharmacology. His research focuses on examining psychedelic treatments such as ketamine, MDMA, and psilocybin for the treatment of existential distress and other mental health conditions. Dr. Byrne is excited to be continuing his work as a member of the outpatient teams at the University of Utah Huntsman Mental Health Institute and at the Huntsman Cancer Hospital.

    Specialties

    Board Certification

    American Board of Psychiatry & Neurology (Psychiatry)

  • Kevin Byrne, MD, Assistant Professor (Clinical), earned his medical degree at Boston University School of Medicine. He completed Adult Psychiatry residency at the University of Utah Spencer Fox Eccles School of Medicine where he served as Chief Resident. He is board certified in Psychiatry by the ABPN. Dr. Byrne's clinical interests include psychiatric care for people with cancer, existential distress, psychedelic treatments for mental health, treatment-resistant mood disorders, trauma and its related conditions, and advanced psychopharmacology. His research focuses on examining psychedelic treatments such as ketamine, MDMA, and psilocybin for the treatment of existential distress and other mental health conditions. Dr. Byrne is excited to be continuing his work as a member of the outpatient teams at the University of Utah Huntsman Mental Health Institute and at the Huntsman Cancer Hospital.

    Board Certification and Academic Information

    Academic Departments Psychiatry -Primary
    Academic Divisions Adult Psychiatry
    Board Certification
    American Board of Psychiatry & Neurology (Psychiatry)

    Education history

    Residency Adult Psychiatry - University of Utah Spencer Fox Eccles School of Medicine Chief Resident
    Adult Psychiatry - University of Utah Spencer Fox Eccles School of Medicine Resident
    Professional Medical Medicine - Boston University School of Medicine M.D.
    Computer Science - Pomona College B.A.

    Selected Publications

    Journal Article

    1. Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking P (2023). HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer. J Pain Symptom Manage, 66(3), 258-269. (Read full article)
    2. Lewis BR, Byrne K, Hendrick J, Garland EL, Thielking P, Beck A (2023). Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial. J Psychedelic Stud. (Read full article)
    3. Byrne KJ, Lindsay S, Baker N, Schmutz C, Lewis B (2023). In naturalistic psychedelic use, group use is common and acceptable. J Psychedelic Stud. (Read full article)
    4. Turner DC, Edmiston AM, Zohner YE, Byrne KJ, Seigfreid WP, Girkin CA, Morris JS, Downs JC (2019). Transient Intraocular Pressure Fluctuations: Source, Magnitude, Frequency, and Associated Mechanical Energy. Invest Ophthalmol Vis Sci, 60(7), 2572-2582. (Read full article)
    5. Keefe KR, Byrne KJ, Levi JR (2018). Treating pediatric post-tonsillectomy pain and nausea with complementary and alternative medicine. Laryngoscope, 128(11), 2625-2634. (Read full article)
    6. Fowler ML, Zhu C, Byrne K, Lieber SB, Moore A, Shmerling RH, Paz Z (2017). Pathogen or contaminant? Distinguishing true infection from synovial fluid culture contamination in patients with suspected septic arthritis. Infection, 45(6), 825-830. (Read full article)

    Review

    1. Lewis BR, Byrne K (2023). A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder. [Review]. Focus (Am Psychiatr Publ), 21(3), 247-256. (Read full article)
    2. Lewis BR, Byrne K (2021). Is MDD the right target for early-stage psychedelic-assisted therapy trials? [Review]. J Psychedelic Stud, 5(2), 65-68. (Read full article)

  • News & Podcasts

    News